Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Zuily

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang <i>et al</i>Medha Barbhaiya, Stephane Zuily, Alison M Hendry, et al.
European Heart Journal|December 18, 2012
Insights from a study by the ESC cardiologists of tomorrow nucleus: the junior cardiologists’ research reveals that the ESC is well regarded by young cardiologists but there is room for improving its appealLukasz Chrzanowski, Ricardo Fontes-Carvalho, Mette Marie Madsen, et al.
Resuscitation|September 6, 2024
Manual versus automatic chest compression devices for cardiopulmonary resuscitation under zero gravity (The MACCC - 0G STUDY)Nathan Reynette, Luc Sagnières, Benjamin Pequignot, et al.
The Journal of Rheumatology|July 3, 2023
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee ReportMedha Barbhaiya, Maxime Taghavi, Stephane Zuily, et al.
Plos One|August 17, 2013
Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAsLeonie Pelkmans, Hilde Kelchtermans, Philip G de Groot, et al.
Current Rheumatology Reports|July 4, 2021
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?Thomas Foret, Virginie Dufrost, Lucie Salomon Du Mont, et al.
European Journal of Preventive Cardiology|March 27, 2012
Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO studyGhassan Moubarak, Laura Ernande, Matthieu Godin, et al.
Autoimmunity Reviews|July 30, 2022
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysisVinicius Domingues, Eugenia Yupei Chock, Virginie Dufrost, et al.
Rheumatology (Oxford, England)|November 18, 2021
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistanceThomas Foret, Virginie Dufrost, Lucie Salomon du Mont, et al.
CJC Open|October 7, 2020
Multiple Arterial Thrombosis in a 78-Year-Old Patient: Catastrophic Thrombotic Syndrome in COVID-19David Kenizou, Clemence Perrin, Ines Harzallah, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|November 21, 2023
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang <i>et al</i>Medha Barbhaiya, Stephane Zuily, Alison M Hendry, et al.
European Heart Journal|December 18, 2012
Insights from a study by the ESC cardiologists of tomorrow nucleus: the junior cardiologists’ research reveals that the ESC is well regarded by young cardiologists but there is room for improving its appealLukasz Chrzanowski, Ricardo Fontes-Carvalho, Mette Marie Madsen, et al.
Resuscitation|September 6, 2024
Manual versus automatic chest compression devices for cardiopulmonary resuscitation under zero gravity (The MACCC - 0G STUDY)Nathan Reynette, Luc Sagnières, Benjamin Pequignot, et al.
The Journal of Rheumatology|July 3, 2023
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee ReportMedha Barbhaiya, Maxime Taghavi, Stephane Zuily, et al.
Plos One|August 17, 2013
Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAsLeonie Pelkmans, Hilde Kelchtermans, Philip G de Groot, et al.
Current Rheumatology Reports|July 4, 2021
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?Thomas Foret, Virginie Dufrost, Lucie Salomon Du Mont, et al.
European Journal of Preventive Cardiology|March 27, 2012
Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO studyGhassan Moubarak, Laura Ernande, Matthieu Godin, et al.
Autoimmunity Reviews|July 30, 2022
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysisVinicius Domingues, Eugenia Yupei Chock, Virginie Dufrost, et al.
Rheumatology (Oxford, England)|November 18, 2021
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistanceThomas Foret, Virginie Dufrost, Lucie Salomon du Mont, et al.
CJC Open|October 7, 2020
Multiple Arterial Thrombosis in a 78-Year-Old Patient: Catastrophic Thrombotic Syndrome in COVID-19David Kenizou, Clemence Perrin, Ines Harzallah, et al.
Pageof 4